Interlinked factors affecting stroke risk in your patients with AF.

Event : Heart Failure 2019

• Session : Solving the puzzle of heart failure, diabetic kidney disease and risk of stroke: let’s fit the pieces together
• Speaker : H Bonnemeier (Kiel,DE)

• Sponsored by Bayer AG

Q&A and closing - Solving the puzzle of heart failure, diabetic kidney disease and risk of stroke: let’s fit the pieces together.

Event : Heart Failure 2019

• Session : Solving the puzzle of heart failure, diabetic kidney disease and risk of stroke: let’s fit the pieces together
• Speaker : M Cowie (London,GB), K Branch (Seattle,US), H Bonnemeier (Kiel,DE), CS Lam (Singapore,SG)

• Sponsored by Bayer AG

Anticoagulation in patients with atrial fibrillation: challenges with continuing protection from hospital to home.

Event : ESC Congress 2016

• Session : Practical management of patients with atrial fibrillation – Individualized approaches to stroke prevention
• Speaker : A Fuat (Darlington,GB), H Bonnemeier (Kiel,DE)

• Sponsored by Bayer Pharma AG

Perspectives from clinical practice: impact of real-world evidence on patient management suggestions.

Event : ESC Congress 2016

• Session : Perspectives from clinical practice: impact of real-world evidence on patient management suggestions
• Speaker : AJ Camm (London,GB), A Fuat (Darlington,GB), H Bonnemeier (Kiel,DE)

• Sponsored by Bayer Pharma AG

Pacing in sinus node disease – are all patients equal?

Event : EHRA 2015

• Session : Sinus node dysfunction: how can basic science improve clinical management?
• Speaker : H Bonnemeier (Kiel,DE)

Characterization of atrial fibrillation onset in patients with ischemic stroke

Event : ESC Congress 2014

• Session : Stroke
• Speaker : H Bonnemeier (Kiel,DE)

Bleeding complications after implantation of active cardiovascular implantable devices in an era of triple therapy and novel antithrombotic drugs.

Event : ESC Congress 2013

• Session : The bad and the ugly of device therapy
• Speaker : H Bonnemeier (Kiel,DE)